San Diego, CA, United States of America

Prognosys Biosciences, Inc.


USPTO Granted Patents = 73


Forward Citations = 5,398

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Mark S Chee (71 out of 182 patents)

silverMedal David A Routenberg (14 out of 14 patents)

bronzeMedal John Andrew Altin (4 out of 4 patents)

4 Igor A Kozlov (3 out of 15 patents)

5 Petr Capek (3 out of 7 patents)

6 David Routenberg (4 patents)


Core Competencies:
Spatially Encoded Biological Assays
Peptide MHC TCR Binding
Nucleic Acid Constructs
Biological Target Analysis
Sample Imaging Techniques
Biological Molecule Probes
Tissue Section Analysis
Assay Systems Development
Spatial Patterns Detection
Biological Target Determination
Peptide Constructs
Biological Assay Methods

73 patents:

Prognosys Biosciences, Inc. is a biotechnology company that specializes in providing innovative solutions for precision medicine. We leverage advanced genomic and bioinformatics technologies to enable the development of personalized therapies and diagnostics. Our team of expert scientists and engineers is dedicated to improving patient outcomes by accelerating drug discovery, optimizing treatment strategies, and enabling targeted interventions. With a strong focus on data-driven solutions, we strive to redefine the field of precision medicine and make a positive impact on healthcare worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

73 Patents

#86 in San Diego, CA

#1,156 in California

#4,849 in US

#9,945 in the World

...
San Diego, CA, United States of America
Forward Citations = 5,398

5 inventors:

Please report any incorrect information to support@idiyas.com
Loading…